Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rectal cancer.

Maria Giulia Zampino1, Roberto Labianca, Giordano Beretta

  • 1European Institute of Oncology, Milan, Italy.

Critical Reviews in Oncology/Hematology
|July 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re-challenge strategies in neuroendocrine tumours: adding another arrow in the quiver?

Cancer treatment reviews·2026
Same author

International variation in child healthcare practices and implications for childhood cancer diagnosis: a scoping review and cross-country clinician survey.

European journal of pediatrics·2026
Same author

Neuroblastoma by Stage at Diagnosis and Other Prognostic Factors: The Results of the BENCHISTA Italian Project-A Population-Based Study.

Cancers·2026
Same author

Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profiling.

Nature reviews. Clinical oncology·2026
Same author

Stage at Diagnosis and International Survival Variation in Childhood Tumors in the BENCHISTA Study.

JAMA network open·2026
Same author

Anti-EGFR rechallenge compared with standard of care for patients with ctDNA RAS/BRAF wild-type chemorefractory metastatic colorectal cancer: A systematic review and meta-analysis.

Critical reviews in oncology/hematology·2026
Same journal

Estrobolome and the Endocrine-Microbiome Axis in Breast and Endometrial Carcinogenesis.

Critical reviews in oncology/hematology·2026
Same journal

Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy.

Critical reviews in oncology/hematology·2026
Same journal

Neoadjuvant immunotherapy in melanoma: From pathologic response to response-adapted management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: Implications for tumor biology and therapeutic strategies - A comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
See all related articles

Integrated treatments, including preoperative radio-chemotherapy, improve survival and reduce recurrence for rectal cancer patients. These updated recommendations aim to enhance patient quality of life.

Area of Science:

  • Oncology
  • Gastroenterology

Background:

  • Rectal cancer is a significant epidemiological concern.
  • It serves as a model for integrated oncological treatments.

Purpose of the Study:

  • To provide updated recommendations for managing rectal cancer patients.
  • To highlight the benefits of integrated treatment approaches.

Main Methods:

  • Review of current oncological practices for rectal cancer.
  • Integration of surgery, radiotherapy, and chemotherapy.

Main Results:

  • Preoperative radio-chemotherapy enhances patient survival.
  • Reduced incidence of pelvic recurrence observed.
  • Improved quality of life for patients is achievable.

Related Experiment Videos

Conclusions:

  • Integrated treatments, particularly preoperative radio-chemotherapy, are crucial for optimal rectal cancer management.
  • Current strategies effectively increase survival and reduce recurrence.
  • Focus on multidisciplinary care improves patient outcomes.